Loading...
BreathID® for pediatrics 2018-03-27T11:16:03+00:00

Test for and confirm eradication of one of the world’s
most common bacterial infections


H. pylori
Infections in children pose future health risks

Often contracted in childhood, the extensive damage of H. pylori infections most often develops from prolonged infections, making early detection a key to quality of life and mitigating later risks.1 Beyond the possible painful gastrointestinal distress symptoms for the child in the present, the carcinogenic H. pylori infection could lead to ulcers in the future and is the strongest known risk factor for developing gastric cancer later in life.2

Did you know?

  • Studies estimate 25% of children in the United States are infected with H. pylori3 (approximately 20 million children based on 2016 US Census Bureau population estimates4).
  • In addition to the known symptoms and effects of H. pylori infections, some studies suggest in certain populations H. pylori infections may delay or even retard growth in pediatric patients.
  • If a child is infected, there is a good chance parents and siblings may also be infected as H. pylori tends to be family clustering, the bacteria passed person-to-person.6 H. pylori becomes a family healthcare issue.

Urea breath tests (UBT) are strongly recommended by clinical guidelines7, for detecting active H. pylori infection – and for confirming eradication of the infection (note: serology antibody testing for H. pylori is no longer within clinical guidelines nor reimbursed by insurance companies.) Further, insurance companies reimburse for UBT H. pylori testing with established CPT Codes.

In-office breath testing

Read More
Point-of-Care testing

Batch testing for labs

Read More
Batch testing for labs

The BreathID Hp urea breath test system for non-invasive H. pylori detection now offers even greater diagnostic power with the addition of a pediatric indication to accurately and easily test patients 3 to 17 years of age. It’s a simple, quick, in-office and kid-friendly test providing market-leading H. pylori detection accuracy. Available as a point-of-care test or as an automated laboratory system, the BreathID Hp technology is the smart choice for your practice, the right choice for your patients.

With market-leading accuracy for H. pylori detection, the BreathID Hp Lab urea breath test system for non-invasive H. pylori detection quickly and easily tests pediatric patients 3 to 17 years of age. Intuitively automated for batch sample analysis, the BreathID Hp Lab test results are interpreted without the need for additional anthropometric calculations, minimizing the potential for human error and making it more efficient and user-friendly compared with competing tests approved for the pediatric market. The BreathID Hp Lab system is the smart choice for your laboratory, the right choice for your patients.

In-office breath testing

Point-of-Care testing
Read More

The BreathID Hp urea breath test system for non-invasive H. pylori detection now offers even greater diagnostic power with the addition of a pediatric indication to accurately and easily test patients 3 to 17 years of age. It’s a simple, quick, in-office and kid-friendly test providing market-leading H. pylori detection accuracy. Available as a point-of-care test or as an automated laboratory system, the BreathID Hp technology is the smart choice for your practice, the right choice for your patients.

Batch testing for labs

Batch testing for labs
Read More

With market-leading accuracy for H. pylori detection, the BreathID Hp Lab urea breath test system for non-invasive H. pylori detection quickly and easily tests pediatric patients 3 to 17 years of age. Intuitively automated for batch sample analysis, the BreathID Hp Lab test results are interpreted without the need for additional anthropometric calculations, minimizing the potential for human error and making it more efficient and user-friendly compared with competing tests approved for the pediatric market. The BreathID Hp Lab system is the smart choice for your laboratory, the right choice for your patients.

References
  1. Guarner J, Bartlett J, Whistler T, et al. “Can pre-neoplastic lesions be detected in gastric biopsies of children with Helicobacter pylori infection?” J Pediatr Gastroenterol Nutr. 2003;37(3):309-314.
  2. National Cancer Institute, “Helicobacter pylori and Cancer,” https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/h-pylori-fact-sheet#q
  3. Staat MA, Kruszon-Moran D, McQuillan GM, Kaslow RA., “A population-based serologic survey of Helicobacter pylori infection in children and adolescents in the United States,” J Infect Dis. 1996;174(5):1120-1123. http://jid.oxfordjournals.org/Content/174/5/ 1120.full.pdf.
  4. US Census Bureau, https://www.census.gov/data/datasets/2017/demo/popproj/2017-popproj.html
  5. Karen J. Goodmana, Pelayo Correac, Robertino Merac, Maria C. Yepezd, Cristina Cerónd, Cristina Campod, Nancy Guerrerod, Mónica S. Sierrae, and Luis E. Bravof, “Effect of Helicobacter pylori Infection on Growth Velocity of School-age Andean Children,” Epidemiology, 2011 January ; 22(1): 118–126. doi:10.1097/EDE.0b013e3181fe7e31.
  6. Malaty H.M., Graham D.Y., “Helicobacter pylori Infection Clusters in Families of Healthy Individuals,” In: Pajares J.M., Peña A.S., Malfertheiner P. (eds) Helicobacter pylori and Gastroduodenal Pathology. Springer, Berlin, Heidelberg
  7. For leading clinical guidelines, see http://www.exalenz.com/clinical-positions/

MTD00296 (BreathID Hp) and MTD00297 (BreathID Hp Lab), 3/18